Minute Insights
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Minute Insight: Haemonetics Buys OpSens To Add Fiber-Optic Sensors For Intervention
Haemonetics will acquire Quebec-based OpSens for CAD $2.90 per share, or about US $253m at current exchange rates. Haemonetics expects OpSens' fiber-optic technology to complement its interventional cardiology portfolio.
Minute Insight: Best Buy Will Sell Dexcom CGM
The retail giant will sell the Dexcom G7 continuous glucose monitoring system to eligible customers through a new online platform.
Minute Insight: Stimdia Starts Trial Of Phrenic Nerve Stimulator For Patients On Ventilators
Stimdia is trying to restore respiratory function in ICU patients with phrenic nerve stimulation.
Minute Insight: Medtronic May Sell Respiratory And Monitoring Units To Private Equity
Reuters reported that global private equity firm Carlyle Group has offered to pay at least $7bn for Medtronic’s patient monitoring and respiratory interventions businesses. Medtronic announced its plan to get out of those businesses about one year ago.
Minute Insight: Cordis-MedAlliance Deal Formalized, Less Than One Year After Announcement
The $1.1bn acquisition of drug-eluting balloon developer MedAlliance will help Cordis return to its roots as an innovative leader in interventional cardiology.
Minute Insight: Enovis Buys Lima To Create Billion-Dollar Recon Business
Enovis has agreed to buy Italian orthopedic implant manufacturer Lima from a private equity firm for €800m – about $845m. The deal will expand Enovis’ presence in the fast-growing international extremities market and improve its manufacturing and innovation facilities.
Minute Insight: Maestro Cues The Music With CE Mark For Moon Surgical
The Paris-based start-up has picked up a CE mark for the latest generation of its Maestro system, a tool designed to make laparoscopic surgery easier and safer.
Minute Insight: Paige Strikes It Big With Microsoft Partnership
The two tech companies – one software giant, the other focused on oncology – will work together on what will likely be the largest artificial intelligence model of its kind.
Minute Insight: Illumina Seeks Stability, Names Thaysen As New CEO
The genome-sequencing giant has named Jacob Thaysen, who brings extensive experience from Agilent, as its new leader.
Minute Insight: Hyfe Goes Physical With Wearable Partnership
The pure-play software company, which has developed a tool to record and monitor patients’ coughs, has signed a partnership to integrate its technology into a wearable.
Minute Insight: Illumina Is Doing Stuff Again – More Leadership Changes
The sequencing technology company, led by an interim CEO, is further shuffling its leadership following the announcement of disappointing mid-year results.
Minute Insight: FTC Pressure Kills Cooper’s Planned Deal For Cook’s Reproductive Assets
Cooper announced a plan to buy Cook’s reproductive health business in February. The deal would have been worth $675m up front and $200m in four annual installments. The US FTC determined the deal would have impaired competition in the reproductive health market.
Minute Insight: Guardant And Illumina Resolve Litigation, Agree To Partnership
Illumina sued Guardant last year, claiming Guardant’s founders stole trade secrets related to blood biopsy diagnostics. The companies have agreed to drop that dispute and share specimen samples for cancer research.
Minute Insight: Augmedics Completes Mop Up Of Surgalign Bankruptcy
Surgalign was forced into bankruptcy after falling foul of the US SEC, leaving Audmedics to pick up its digital health assets for the bargain price of $900,000.
Minute Insight: ViewRay Is Going Out Of Business, Blames Order Backlog
ViewRay will continue to maintain its MRI-guided radiation therapy systems at customer sites, but filed for Chapter 11 bankruptcy protection and is planning to sell the business’ assets.
Minute Insight: Medtronic Received Medicare Coverage For New MiniMed 780G Insulin Pump
Medtronic has secured coverage to market its recently approved MiniMed 780G insulin pump to eligible Medicare and Medicare Advantage beneficiaries, opening access to more patients after a long delay in bringing the device to the US market.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.